Cases 1 - 3 of 3
In re: MDL 2700 Genentech
as 19-5035
Plaintiff / Appellant:
TENNESSEE ONCOLOGY, PLLC, a Tennessee Professional Limited Liability Corporation, FLORIDA CANCER SPECIALISTS, P.L., a Florida Professional Limited Liability, VIRGINIA CANCER INSTITUTE, a Virginia Commonwealth Professional Corporation and others
Defendant:
ROCHE HOLDING LTD., ROCHE HOLDINGS, INC. and ROCHE HOLDING AG
Defendant / Appellee:
GENENTECH, INC., a California Corporation
Oncology-Hematology Associates of Central Illinois P.C. v. Genentech, Inc.
as 4:2017cv00394
Plaintiff:
Oncology-Hematology Associates of Central Illinois P.C.
Defendant:
Genentech Inc.
Cause Of Action: MDL 2700 Genentech Herceptin (Trastuzumab) Marketing and Sales Practices Litigation
Oncology-Hematology Associates of Central Illinois P.C. v. Genentech, Inc.
as 1:2017cv01279
Plaintiff:
Oncology-Hematology Associates of Central Illinois P.C.
Defendant:
Genentech, Inc.
Cause Of Action: 28 U.S.C. ยง 1332
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
